3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
1
Hodgkin Disease
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Nivolumab
3
Gemcitabine
3
pembrolizumab
2
vandetanib
1
temsirolimus
1
sargramostim
1
motexafin gadolinium
1
motesanib diphosphate
1
durvalumab
1
cc-486
1
carboxyamido-triazole
1
belinostat
1
atezolizumab
1
advexin
1
Watchful Waiting
1
Vorinostat
1
Topotecan
1
TTI-621
1
Specimen Handling
1
Rituximab
1
Ritonavir
1
Radiotherapy
1
RXDX-106
1
Polymerase Chain Reaction
1
Paclitaxel
1
Nicotine
1
Microarray Analysis
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Levofloxacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
RXDX-106
×
Thoracic
×
Clear all
NCT03454243
2019-04-25
TITAN
Hoffmann-La Roche
Phase EARLY_PHASE1
Terminated
1 enrolled